GAMCO Investors’s Impax Laboratories, Inc. IPXL Stock Holding History

GAMCO Investors’s Portfolio IPXL Stock Details IPXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-6,775	Closed	-$215K	–	857
2014 Q4	$215K	Buy	+6,775	New	+$198K	﹤0.01%	817

Other funds holding IPXL

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Aravt Global New York $11.3M AUM 3.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PCM

Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

SPC

Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return

GAMCO Investors's IPXL Position: Q1 2015 in Review

GAMCO Investors sold out of Impax Laboratories, Inc. (IPXL) in Q1 2015, closing a stake of 6,775 shares — an estimated $215K sold.

GAMCO Investors first reported a position in IPXL in Q4 2014 and held it in 1 quarter. The position peaked at $215K in Q4 2014. 197 funds tracked by Wall St. Rank hold IPXL as of Q1 2015.

GAMCO Investors reported no remaining Impax Laboratories, Inc. position as of Q1 2015 after selling out during the quarter.
GAMCO Investors sold 6,775 Impax Laboratories, Inc. shares in Q1 2015, an estimated $215K.
GAMCO Investors first reported a position in Impax Laboratories, Inc. in Q4 2014 and held it in 1 quarter.
GAMCO Investors's Impax Laboratories, Inc. position peaked at $215K in Q4 2014.
197 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q1 2015.

Based on GAMCO Investors's 13F filing for Q1 2015, filed 1 May 2015.